Skip to main navigation
  • About
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Clinical And Scientific Advisors
    • Contact
  • Science
    • Immune Continuum
    • CCR4 in Cancer
    • CCR4 in Inflammation
    • GCN2
    • Publications
  • Pipeline
    • Snapshot
    • FLX475
    • RPT193
    • GCN2i
    • HPK1
    • Discovery Programs
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Email Alerts
    • Investor Contact
    • Investor FAQs
  • Careers
    • Culture
    • Benefits
    • Open Positions

Events and Presentations

Events and Presentations

Presentations
Documents
January 2023 Corporate Presentation
Phase 1/2 study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer, ESMO-IO 2022
September 2022 Corporate Presentation
2022 American Academy of Dermatology (AAD) Annual Meeting Presentation, March 26, 2022
Inflammatory Skin Disease Summit (ISDS) Presentation, November 3, 2021
RPT193 2021 EADV Congress Presentation, September 30, 2021
RAPT Therapeutics RPT193 Phase 1 B Data Presentation
RAPT Therapeutics Initial Data Readout for FLX475
FLX475 American Society for Clinical Oncology, May 29, 2020
RPT193 Society for Investigative Dermatology Presentation, May 15, 2020
Upcoming Events
There are no upcoming events available at this time.
Past Events
Date Event Details
Jan 10, 2023 at 3:00 PM PST
41st Annual J.P. Morgan Healthcare Conference
Click here for webcast
Jun 14, 2021 at 8:30 AM EDT
RAPT Therapeutics RPT193 Phase 1 B Data Call
Click here for webcast
RAPT Therapeutics RPT193 Phase 1 B Data Presentation 1 MB
Shareholder tools
Print page
RSS feeds
Share page
E-mail alerts
  • Facebook1
  • LinkedIn
  • Twitter
Contact Us
+1.650.489.9000
inquiries@rapt.com
  • Home
  • About
  • Science
  • Pipeline
  • Investors
  • Careers
  • Terms of Use
  • Privacy Policy

RAPT Therapeutics, Inc.
561 Eccles Avenue
South San Francisco, CA 94080

RAPT Therapeutics, formerly known as FLX Bio.

© RAPT Therapeutics , Inc. All right reserved.